Revance Therapeutic (RVNC) PT Raised to $3.65 at Mizuho
Tweet Send to a Friend
Mizuho analyst Vamil Divan raised the price target on Revance Therapeutic (NASDAQ: RVNC) to $3.65 (from $3.10) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
